The substance use disorder (SUD) treatment industry is navigating a dynamic landscape shaped by macroeconomic factors, such as interest rates and inflation. While these...
In the ever-changing landscape of healthcare, substance use disorder (SUD) treatment has evolved significantly over the past few decades. From the early days of...
M&A experts predict 2021 will bring a wave of behavioral health transactions as investors and strategic buyers, finding fewer attractive targets in other industries,...
As the United States transitions into a new presidential administration, behavioral health leaders are closely watching what the future holds. With Joe Biden set...
The Drug Enforcement Administration (DEA) is facing mounting pressure from leading health care and behavioral health organizations for failing to create a special telehealth...